CN1320901C - Medicine for treating lung carbuncle disease - Google Patents
Medicine for treating lung carbuncle disease Download PDFInfo
- Publication number
- CN1320901C CN1320901C CNB2004100406030A CN200410040603A CN1320901C CN 1320901 C CN1320901 C CN 1320901C CN B2004100406030 A CNB2004100406030 A CN B2004100406030A CN 200410040603 A CN200410040603 A CN 200410040603A CN 1320901 C CN1320901 C CN 1320901C
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- present
- chinese medicine
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses medicine for treating lung carbuncle diseases, which is prepared into an oral liquid preparation from seven tastes of Chinese medicine such as 10 parts by weight of houttuynia, 10 parts of dandelion, 10 parts of rose moss, 5 parts of almonds, 5 parts of balloonflower, 8 parts of mulberry bark and 8 parts of forsythia. After the present invention is clinically applied, body temperature of a patient rapidly drops; after the patient takes the medicine for 4 to 6 days, the body temperature gradually returns to normality, and the poisoning symptom of the whole body is reduced. The medicine prompts the purulent phlegm of a lung vomica to rapidly discharge so that a focus is cured early. The present invention has the advantages of good therapeutic effect and no toxic side effect. In addition, because the Chinese medicine adopted in the recipe of the present invention is common ordinary Chinese medicine with low price, the present invention used for treating lung carbuncle diseases also has the advantage of low therapeutic expense.
Description
Technical field:
The present invention relates to a kind of medicine for the treatment of the lung abscess disease, belong to treatment pneumonopathy technical field of pharmaceuticals.
Background technology:
Lung abscess is a kind of common disease, and is just on the books in " Waike Zhengzong, Orthodox Manual of External Diseases " that Ming Dynasty's Chen Shigong is shown: " lung abscess person, the disease that gold goes to the stake also.Cough a lot of phlegm, yellow raw meat is dirty ", in the Golden Mirror of Medicine that the Wu Qian of the Qing Dynasty is shown, also mention: " lung abscess shape such as typhoid fever cough caused by dryness very, thick turbid sputum smell as of rotten fish pus ".This disease, often onset is hurried, and slight cold and heat are just arranged, and increases the weight of gradually then, and body temperature can reach 39～40 ℃, and the moderate cough is violent sometimes, and expectorant elder generation show bubble is later on a large amount of purulent sputums or sanguinopurulent expectorant or spitting of blood gradually.This disease has a strong impact on patient's work capacity and quality of life.Though it is more to treat the medicine of this disease at present, but it is higher that ubiquity expenses for medicine, and the also less-than-ideal problem of curative effect, and existing medicine great majority are Western medicine, though these Western medicine have certain curative effect, it exists the phenomenon of toxic and side effects also relatively more serious.Therefore, the result of use of existing treatment lung abscess disease medicament still is not ideal.
Summary of the invention:
The objective of the invention is: provide a kind of therapeutic effect better, have no side effect, the medicine of treatment lung abscess that medical expense is lower, to overcome the deficiencies in the prior art.
The present invention is achieved in that this medicine is made into oral liquid formulations by Herba Houttuyniae, Herba Taraxaci, Herba Portulacae Grandiflorae, Semen Armeniacae Amarum, Radix Platycodonis, Cortex Mori and Fructus Forsythiae seven flavor Chinese medicines, each medicine proportioning by weight of distinguishing the flavor of is as follows: respectively 10 parts of Herba Houttuyniae, Herba Taraxaci, Herba Portulacae Grandifloraes, each 5 parts of Semen Armeniacae Amarum and Radix Platycodoniss, each 8 parts of Cortex Mori and Fructus Forsythiaes.
In prescription of the present invention: Herba Houttuyniae has the effect of heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, inducing diuresis for treating stranguria syndrome, and modern pharmacology experiment shows, effects such as that this medical instrument has is antibiotic, antiviral, human body immunity improving power, diuresis; Cold in nature, the sweet-bitter flavor of Herba Taraxaci has the effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, dampness removing jaundice eliminating, proves that through modern medicine study Herba Taraxaci also has stronger sterilization and antiviral, function of gallbladder promoting, diuresis, effect is good for the stomach; Herba Portulacae Grandiflorae property is flat, and acrid in the mouth is little, has detoxifcation and invigorates blood circulation, the effect of detumescence softening the hard mass; Semen Armeniacae Amarum is a rosaceous plant, and property is sweet, bitter, warm, has relieving cough and resolving phlegm ， Run Intestinal relieving constipation, and bitter drop-down gas and the effect of cough-relieving are usually used in diseases such as treatment cough, asthma clinically; Radix Platycodonis is the campanulaceae herbaceos perennial, with root people medicine, the effect of lung qi dispersing, cold expelling, nuclear expectorant, evacuation of pus is arranged; Cortex Mori is a moraceae plants, has sweet trembling with fear into lung meridian, eliminating pathogen from the lung for relieving asthma, the effect of line water detumescence; Fructus Forsythiae is a conventional Chinese medicine, cold nature, and bitter in the mouth, it has the function of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, is usually used in treating diseases such as carbuncle, scrofula, acute mastitis, erysipelas clinically.
After the present invention carries out rational formula with the above-mentioned Chinese medicine that has no side effect commonly used, make the Chinese medicine of respectively distinguishing the flavor of to coordinate mutually to bring into play its property of medicine jointly, so the present invention have the effect of heat-clearing and toxic substances removing, the toxin expelling that eliminates the phlegm, relieving cough and resolving phlegm, heat extraction eliminating stagnation preferably.The present invention is after clinical practice, and it is very fast that patient temperature is descended, and 4～6 days body temperature in back of taking medicine recovers normally gradually, and the whole body poisoning symptom improves, and it can impel the very fast discharge of purulent sputum of pulmonary's vomica, makes focus secondary closure early.The present invention compares with the medicine of existing treatment lung abscess disease, the present invention has the advantage that therapeutic effect is better, have no side effect, in addition because the Chinese medicine that is adopted in the prescription of the present invention all is common and cheap common Chinese, therefore adopt the present invention to treat the lung abscess disease, also have the lower advantage of medical expense.
The specific embodiment:
Embodiments of the invention: get Herba Houttuyniae, Herba Taraxaci, each 30 gram of Herba Portulacae Grandiflorae, each 15 gram of Semen Armeniacae Amarum and Radix Platycodonis, each 24 gram of Cortex Mori and Fructus Forsythiae, and add after 1000 ml waters fully are mixed into medicinal liquid, the processing technology of oral liquid is endured medicinal liquid and is concentrated into 100 milliliters routinely again, can make oral liquid formulations of the present invention.The instructions about how to take medicine of oral liquid formulations are: every day 2～3 times, each 30～50 milliliters, use warm water delivery service.
Be the clinical observation of adopting the present invention to treat the lung abscess patient below, so that curative effect of the present invention is further described:
Medical history patient began heating before a week, cough, and abundant expectoration, by " going up scorching " treatment, symptom does not subtract behind the medicine through certain hospital, and heating and cough increase the weight of, and bottom right chest pain pain, tachypnea, dizziness, headache occur.
Patient temperature is 39.5 ℃ on inspection, lethargy, and chronic facies, rapid breathing, bottom right lung percussion is turbid, and respiratory murmur lowers, and wet sound rale is arranged.Through the laboratory examination blood samples of patients: it is from 12800/ cubic millimeter of total cellular score, and neutral 79%.Admittedly determine that the patient is lung abscess disease patient.
After adopting the present invention that the patient is treated 4 days, the patient is carried out further consultation, its febrile lysis, body temperature are 38.3 ℃, the cough tachypnea, and right chest pain alleviation of pain is light, and the apoplexy due to phlegm blood streak disappears.
Continuation is adopted the present invention to treat after 4 days further consultation again to the patient and observed: patient temperature is 37.2 ℃, cough with copious phlegm, and chest pain significantly alleviates.
The patient continues to take the present invention again and treats further consultation observation after 4 days: body temperature is 36.5 ℃, and the expectoration rareness has not had chest pain.Through the X-ray check, big absorption of bottom right lung yin shadow, the fluid level is not obvious.
The patient continues to take the present invention again and treats after a week again through X-ray examination: its bottom right lung yin shadow all absorbs, the symptom recovery from illness.
Taking during the present invention treats, any untoward reaction does not appear in the patient.
Claims (1)
1, a kind of medicine for the treatment of the lung abscess disease, it is characterized in that: this medicine is made into oral liquid formulations by Herba Houttuyniae, Herba Taraxaci, Herba Portulacae Grandiflorae, Semen Armeniacae Amarum, Radix Platycodonis, Cortex Mori and Fructus Forsythiae seven flavor Chinese medicines, get Herba Houttuyniae, Herba Taraxaci, each 30 gram of Herba Portulacae Grandiflorae, each 15 gram of Semen Armeniacae Amarum and Radix Platycodonis, each 24 gram of Cortex Mori and Fructus Forsythiae, and add after 1000 ml waters fully are mixed into medicinal liquid, medicinal liquid is endured be concentrated into 100 milliliters again, can make oral liquid formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100406030A CN1320901C (en) | 2004-09-01 | 2004-09-01 | Medicine for treating lung carbuncle disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100406030A CN1320901C (en) | 2004-09-01 | 2004-09-01 | Medicine for treating lung carbuncle disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1596952A CN1596952A (en) | 2005-03-23 |
| CN1320901C true CN1320901C (en) | 2007-06-13 |
Family
ID=34664729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100406030A Expired - Fee Related CN1320901C (en) | 2004-09-01 | 2004-09-01 | Medicine for treating lung carbuncle disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1320901C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908444A (en) * | 2012-10-30 | 2013-02-06 | 杨晨 | Miao drug for treating lung disease |
| CN104435827A (en) * | 2014-11-19 | 2015-03-25 | 刘新霞 | Traditional Chinese medicine preparation for treating convalescent pulmonary abscess disease |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1470277A (en) * | 2003-07-07 | 2004-01-28 | 赵万哩 | Chinese medicine for treating lung diseases by external application |
-
2004
- 2004-09-01 CN CNB2004100406030A patent/CN1320901C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1470277A (en) * | 2003-07-07 | 2004-01-28 | 赵万哩 | Chinese medicine for treating lung diseases by external application |
Non-Patent Citations (3)
| Title |
|---|
| 以射干前胡汤为主治疗慢性支气管炎急性感染52例 杨善栋等，四川中医，第16卷第4期 1998 * |
| 清肺糖浆(散)治疗小儿肺热咳嗽300例的疗效观察 陈宋娟等，实用医学杂志，第7卷第3期 1991 * |
| 清肺糖浆(散)治疗小儿肺热咳嗽300例的疗效观察 陈宋娟等，实用医学杂志，第7卷第3期 1991;以射干前胡汤为主治疗慢性支气管炎急性感染52例 杨善栋等，四川中医，第16卷第4期 1998 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1596952A (en) | 2005-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105012392A (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
| CN101138613A (en) | Traditional Chinese medicine for treating acute bronchitis of children | |
| CN1320901C (en) | Medicine for treating lung carbuncle disease | |
| CN105288200A (en) | Traditional Chinese medicine preparation for treating children bronchial asthma and preparation method thereof | |
| CN101085339A (en) | Traditional Chinese medicine composition for curing chronic nephritis | |
| CN1335174A (en) | Stomatopathy and throat disease treating health care medicine and its production process | |
| CN102793868B (en) | Preparation method of traditional Chinese medicine lotion for treating rapid respiration type closed fracture | |
| CN102552789B (en) | Chinese medicine for treating damp-warm flu and preparation method and application thereof | |
| CN105233252A (en) | Chinese and western medicine compound preparation for treating acute suppurative cholangitis | |
| CN104998074A (en) | Traditional Chinese medicine for treating gastropathy and preparation method thereof | |
| CN116492432B (en) | Traditional Chinese medicine mixture for treating lung syndrome caused by pathogenic heat of virus infection | |
| CN103251701B (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN102670959B (en) | Anti-influenza Chinese herba preparation and preparation method thereof | |
| CN101181420B (en) | Chinese medicine composition externally used for curing tinea unguium | |
| CN106266720A (en) | A kind of Chinese medicine composition and preparation method that can effectively treat chronic pharyngitis | |
| CN1232280C (en) | Jiedufeitai medicine for disintoxication and beneficial to lung | |
| CN104491662A (en) | Traditional Chinese preparation used for treating initial measles | |
| CN1103599C (en) | Chenxia medicament for relieving asthma and its pren. tech. | |
| CN105031556A (en) | Chinese herb preparation for treating cough variant asthma | |
| CN111202790A (en) | Traditional Chinese medicine for treating cold | |
| CN112546194A (en) | Oral liquid for relieving chest stuffiness and regulating qi | |
| CN117503898A (en) | Traditional Chinese medicine composition for treating asthma and application thereof | |
| CN106421409A (en) | Traditional Chinese medicine preparation for treating stomach illness and preparation method thereof | |
| CN109464646A (en) | Ointment formula, preparation method and application are massaged in cough-relieving paediatrics external application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |